These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31858769)

  • 1. Co-existence of VIM-2-producing
    Palavecino E; Ramirez K; Greene SR; Kilic A
    Ann Lab Med; 2020 May; 40(3):267-269. PubMed ID: 31858769
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of multiple carbapenemase-producing Gram-negative species, colistin-resistant KPC-2-producing Klebsiella pneumoniae ST11, IMP-7-producing Pseudomonas aeruginosa ST357, and OXA-23-producing Acinetobacter baumannii ST1050, in a single patient.
    Nishida S; Ishigaki S; Asahara M; Furukawa T; Ono Y
    Int J Antimicrob Agents; 2018 Oct; 52(4):512-514. PubMed ID: 30318057
    [No Abstract]   [Full Text] [Related]  

  • 3. First Detection of VIM-4-Producing Pseudomonas aeruginosa and OXA-48-Producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria.
    Mellouk FZ; Bakour S; Meradji S; Al-Bayssari C; Bentakouk MC; Zouyed F; Djahoudi A; Boutefnouchet N; Rolain JM
    Microb Drug Resist; 2017 Apr; 23(3):335-344. PubMed ID: 27314660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
    Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
    J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular detection of the bla
    Ribeiro PC; Monteiro AS; Marques SG; Monteiro SG; Monteiro-Neto V; Coqueiro MM; Marques AC; de Jesus Gomes Turri R; Santos SG; Bomfim MR
    BMC Infect Dis; 2016 Dec; 16(1):737. PubMed ID: 27927163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.
    Williamson DA; Heffernan H; Sidjabat H; Roberts SA; Paterson DL; Smith M; Freeman JT
    J Antimicrob Chemother; 2011 Dec; 66(12):2888-90. PubMed ID: 21933789
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers.
    Miriagou V; Tzelepi E; Kotsakis SD; Daikos GL; Bou Casals J; Tzouvelekis LS
    Clin Microbiol Infect; 2013 Sep; 19(9):E412-5. PubMed ID: 23627340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KPC-2-producing Klebsiella pneumoniae in Brazil: a widespread threat in waiting?
    Zavascki AP; Zoccoli CM; Machado AB; de Oliveira KR; Superti SV; Pilger DA; Cantarelli VV; Barth AL
    Int J Infect Dis; 2010 Jun; 14(6):e539-40. PubMed ID: 19889563
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.
    Pasteran F; Faccone D; Petroni A; Rapoport M; Galas M; Vázquez M; Procopio A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342
    [No Abstract]   [Full Text] [Related]  

  • 10. Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae.
    Sun D; Rubio-Aparicio D; Nelson K; Dudley MN; Lomovskaya O
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 29038260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of KPC-producing Klebsiella pneumoniae in Texas.
    Hirsch EB; Chang KT; Lasco TM; Caeiro JP; Tam VH
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):234-5. PubMed ID: 21251574
    [No Abstract]   [Full Text] [Related]  

  • 12. Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa.
    Iannaccone M; Boattini M; Bianco G; Cavallo R; Costa C
    Int J Antimicrob Agents; 2020 Aug; 56(2):106066. PubMed ID: 32599226
    [No Abstract]   [Full Text] [Related]  

  • 13. Meropenem heteroresistance in clinical isolates of OXA-48-producing Klebsiella pneumoniae.
    López-Camacho E; Paño-Pardo JR; Sotillo A; Elías-López C; Martínez-Martínez L; Gómez-Gil R; Mingorance J
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):162-166. PubMed ID: 30297092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of colistin resistance in OXA-181 carbapenemase-producing Klebsiella pneumoniae ST3130 in Japan.
    Hayashi W; Togashi M; Taniguchi Y; Koide S; Nagano Y; Nagano N
    J Glob Antimicrob Resist; 2018 Mar; 12():179-180. PubMed ID: 29414724
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods.
    Camarlinghi G; Parisio EM; Antonelli A; Nardone M; Coppi M; Giani T; Mattei R; Rossolini GM
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):74-76. PubMed ID: 30126624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase.
    Hornsey M; Phee L; Woodford N; Turton J; Meunier D; Thomas C; Wareham DW
    J Clin Pathol; 2013 Apr; 66(4):348-50. PubMed ID: 23288920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of multi-drug resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from clinical specimens at Bugando Medical Centre, Tanzania to Piperacillin-Tazobactam.
    Petro D; Mushi MF; Moremi N; Iddi S; Mirambo M; Seni J; Mshana SE
    Tanzan J Health Res; 2014 Jan; 16(1):54-7. PubMed ID: 26867273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.
    Kazmierczak KM; Biedenbach DJ; Hackel M; Rabine S; de Jonge BL; Bouchillon SK; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4490-500. PubMed ID: 27161636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.